Form 4: VYNE Therapeutics Executive Sells Shares to Cover Tax Obligations

Mutya Harsch, Chief Legal Officer and GC of VYNE Therapeutics, sold shares to cover tax withholding requirements related to vesting restricted stock units.

Summary

• On July 1, 2024, Mutya Harsch, the Chief Legal Officer and General Counsel of VYNE Therapeutics Inc., engaged in a transaction involving the company's common stock.
• Harsch disposed of 143 shares to cover tax withholding requirements related to the vesting of restricted stock units.
• The shares were sold at a price of $1.92 per share.
• Following the transaction, Harsch directly owns 149,131 shares of VYNE Therapeutics Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, which is a common practice for corporate insiders.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. These filings provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it involves a small number of shares and is related to tax obligations.

Key Dates